On Friday, A24 opened You Can See Everything in limited release: two hours and fifty-four minutes of Nathan Fielder and Lance Oppenheim trailing Elizabeth Holmes through the thirty-four days before she reported to prison, and then, per the studio’s own synopsis, a “three-year journey into the abyss.” By Saturday the argument was fully formed — on Hacker News, in the New Yorker’s October 19 pages, on every film podcast with a spare ninety minutes — and the argument is whether the movie is deceiving you.

It probably is. That is the least interesting true thing about it.

The Deception Debate Has a Publicist

Richard Brody, reviewing the film for The New Yorker, called it “a compelling spectacle of manipulation, suspicion, and apparent sincerity.” NPR’s critic observed that Fielder ends up trusting his gut and his own conversations with Holmes over the enormous body of reporting that already exists. Next Best Picture flagged the film’s “blind spots.” The R rating is for language and some graphic nudity, which tells you something about how much of the runtime is spent on Holmes as a person rather than Holmes as a defendant.

So the critics and the defenders agree on the diagnosis. The disagreement is only about whether being deceived by a documentary is bearable.

That is not a scandal. That is a trailer that writes itself. As a booker for a Midwestern art-house chain put it to me between scheduling calls, “Nobody buys a ticket to watch a woman be accurately described.” He is not being cynical. He is describing the product. A24 is the most brand-conscious distributor in the country, and “is it lying to you?” is the cheapest marketing copy in the medium — cheaper than a poster, cheaper than a trailer, and it comes with a built-in chyron for every segment producer in New York.

A Jury Already Answered the Question the Film Keeps Reopening

Holmes is serving an eleven-year sentence for defrauding investors in Theranos. That happened. There was a trial, a verdict, a judge, a marshals’ van. The factual question is closed.

What the film does instead is reopen the epistemic question — can you ever really know what she meant? — and that is a much more comfortable question to sit with for three hours, because it has no victims in it. The most damning line in any of the reviews is Next Best Picture noting the film’s blind spots “especially around the real victims.” Read that again. The people who put money and blood into a machine that could not do what it claimed are treated as a gap in the edit, and then the gap is described as a flaw rather than a choice.

It is a choice. Victims don’t generate discourse. A founder in a black turtleneck, lit like a confessional, generating discourse — that generates discourse. If the film were honest about its own structure it would have a title card explaining that the audience is now participating in the exact preference that built Theranos in the first place: the story over the documentation, the founder over the file.

Prosecution Without a Story Is Just a Press Release

Here is where my own side should get uncomfortable.

The standard conservative reaction to a film like this is a sneer at the coastal industry for getting played, followed by a call for more prosecution. But we already won the prosecution. The Department of Justice won it. The SEC won it. There was no leniency, no wrist slap, no soft landing on a board seat. She went to prison.

And what did the public get out of that victory? A sentencing memorandum and a docket. A docket nobody reads, because it is written for people who bill by the hour. There is no plain-language accounting of what happened to the money, what happened to the patients, what happened to the technology after the cameras left the courtroom. The state proved its case and then declined to explain it. Into that silence walks a comedy director with a three-year access agreement, and we act surprised that he now owns the definitive record of the aftermath.

That is the indictment. Not that Holmes fooled Nathan Fielder — she may or may not have, and the film is interesting precisely because it won’t say. The indictment is that a private distributor and two filmmakers have now produced the most legible account of what Theranos did and what it cost, and the only reason they could is that the official institutions treated the story as beneath them.

Law-and-order politics has a blind spot exactly this shape. It budgets for convictions and not for narration, then wonders why the public remembers the movie instead of the verdict. A restitution order nobody can read is functionally a press release. It punishes. It does not teach.

The cheaper fix is not another documentary. It is the boring thing: publish the ledger. Name the buyers. Show the patients. Do it at the courthouse door on the day of sentencing, in sentences short enough to be repeated. That costs nothing and it steals the entire genre out from under the people who currently own it.

Instead, You Can See Everything heads to the Stockholm Film Festival in November and a U.K. release the same month, and the deception debate will keep the seats full right through awards season. It is a good film, by most accounts. That is the problem. The people who could have made it irrelevant — the ones with subpoena power and a press office — chose not to, and now we are all sitting in the dark, watching a fraudster explain herself to a man with a microphone, and calling it a controversy when it is really an inheritance nobody else wanted.

Sources